1. Efficacy and Safety of Canagliflozin in Individuals Aged 75 and Older with Type 2 Diabetes Mellitus: A Pooled Analysis. Issue 3 (March 2016) Authors: Sinclair, Alan J.; Bode, Bruce; Harris, Stewart; Vijapurkar, Ujjwala; Shaw, Wayne; Desai, Mehul; Meininger, Gary Journal: Journal of the American Geriatrics Society Issue: Volume 64:Issue 3(2016:Mar.) Page Start: 543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Meta‐analysis of insulin aspart versus regular human insulin used in a basal–bolus regimen for the treatment of diabetes mellitus (在基础—餐时糖尿病治疗方案中使用门冬胰岛素与使用常规人胰岛素对照研究的Meta分析). (7th May 2013) Authors: Heller, Simon; Bode, Bruce; Kozlovski, Plamen; Svendsen, Anne Louise Journal: Journal of diabetes Issue: Volume 5:Number 4(2013:Oct.) Page Start: 482 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Preserved pharmacokinetic exposure and distinct glycemic effects of insulin degludec and liraglutide in IDegLira, a fixed‐ratio combination therapy. (14th July 2015) Authors: Kapitza, Christoph; Bode, Bruce; Ingwersen, Steen Hvass; Jacobsen, Lisbeth Vestergård; Poulsen, Pernille Journal: Journal of clinical pharmacology Issue: Volume 55:Number 12(2015:Dec.) Page Start: 1369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States. (July 2020) Authors: Bode, Bruce; Garrett, Valerie; Messler, Jordan; McFarland, Raymie; Crowe, Jennifer; Booth, Robby; Klonoff, David C. Journal: Journal of diabetes science and technology Issue: Volume 14:Number 4(2020:Jul.) Page Start: 813 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial. Issue 7 (July 2019) Authors: Pieber, Thomas R; Bode, Bruce; Mertens, Ann; Cho, Young Min; Christiansen, Erik; Hertz, Christin L; Wallenstein, Signe O R; Buse, John B Journal: Lancet Issue: Volume 7:Issue 7(2019) Page Start: 528 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial. Issue 4 (April 2021) Authors: von Herrath, Matthias; Bain, Stephen C; Bode, Bruce; Clausen, Jesper Ole; Coppieters, Ken; Gaysina, Leylya; Gumprecht, Janusz; Hansen, Troels Krarup; Mathieu, Chantal; Morales, Cristobal; Mosenzon, Ofri; Segel, Stine; Tsoukas, George; Pieber, Thomas R; Ludvik, Bernhard; Prager, Rudolf; Paulweber,... Journal: Lancet Issue: Volume 9:Issue 4(2021) Page Start: 212 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Economic impact of hypoglycemia among insulin-treated patients with diabetes. (1st November 2016) Authors: Sussman, Matthew; Sierra, Joseph A; Garg, Satish; Bode, Bruce; Friedman, Mark; Gill, Max; Kaufman, Francine; Vigersky, Robert; Menzin, Joseph Journal: Journal of medical economics Issue: Volume 19:Number 11(2016) Page Start: 1099 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Elevated Serum Levels of Soluble TNF Receptors and Adhesion Molecules Are Associated with Diabetic Retinopathy in Patients with Type-1 Diabetes. (3rd August 2015) Authors: Sharma, Shruti; Purohit, Sharad; Sharma, Ashok; Hopkins, Diane; Steed, Leigh; Bode, Bruce; Anderson, Stephen W.; Caldwell, Ruth; She, Jin-Xiong Other Names: Szodoray Peter Academic Editor. Journal: Mediators of inflammation Issue: Volume 2015(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: A multicentre, randomized controlled trial using continuous glucose monitoring. Issue 8 (9th May 2019) Authors: Pettus, Jeremy; Gill, Jasvinder; Paranjape, Sachin; Stewart, John; Malla, Shilpy; Edelman, Steven; Bergenstal, Richard M.; Bode, Bruce Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 8(2019) Page Start: 1906 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy, safety, tolerability, and noninferiority phase 3 study of glucagon as a ready‐to‐use room temperature liquid stable formulation versus a lyophilised formulation for the biochemical recovery and symptomatic relief of insulin‐induced severe hypoglycaemia in adults with type 1 diabetes. Issue 7 (28th April 2022) Authors: Pieber, Thomas R.; Aronson, Ronnie; Christiansen, Mark P.; Bode, Bruce; Junaidi, Khaled; Conoscenti, Valentina Journal: Diabetes, obesity & metabolism Issue: Volume 24:Issue 7(2022) Page Start: 1394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗